Victrex Shares Jump 18% After Third-Quarter Revenue Growth Beats Prior Year

Victrex shares surged on Tuesday after the polymer maker reported an 18% rise in third-quarter revenue and held its full-year profit guidance steady.

Victrex plc, (LON:VCT) the Lancashire-based maker of PEEK high-performance polymers, saw its share price jump after publishing a trading update before markets opened on Tuesday. The update showed strong volume growth across its aerospace and electronics markets.

Shares are trading at around 684p on Tuesday morning, up roughly 17.5% on the session, having earlier touched an intraday high of 690p. The stock closed at 582p on Monday. It remains within its 52-week range of 515p to 756p, both levels confirmed against Victrex’s trading history over the past year.

Aerospace and electronics lead the recovery

According to Victrex’s regulatory filing, group revenue for the third quarter rose 18% year-on-year to £84.5 million, with sales volumes up 17% to 1,238 tonnes. Average selling prices held at £68 per kilogram, in line with the prior year. For the nine months to 30 June, revenue rose 6.6% to £231.6 million. Aerospace and electronics were the main drivers, with aerospace benefiting from a weaker prior-year comparator tied to 2025 supply chain backlogs, while the company said its medical division showed some stabilisation.

Victrex confirmed it remains on track to deliver at least £10 million in annualised cost savings by its 2027 financial year, having already cut headcount by around 10% under its profit improvement plan, with most affected staff having left during the third quarter. The board maintained its guidance for underlying pre-tax profit of £42 million to £44 million for the current financial year. Net debt stood at £43 million as of 30 June, after payment of the interim dividend of 13.42p per share.

The update marks a continuation of the recovery trend Victrex flagged at its half-year results in May, when management said trading had improved through the second quarter following a weak start to the year that included a China plant impairment and a reported pre-tax loss.

Chief Executive James Routh said: “Q3 maintained the positive momentum we saw through our second quarter. Compared to the prior year, revenue growth was driven by improvement across several end markets, particularly Aerospace and Electronics, with some stabilisation in Medical.” He added that the company remains “focused on driving significant improvement in profitability over the medium term.”

Markets have taken comfort from the maintained profit guidance and continued demand from aerospace and electronics customers, alongside progress on cost cuts, even as the report noted recent revenue declines and weaker cash generation over the past year as ongoing risks.

Victrex will host a capital markets event titled “Unlocking Victrex’s Potential” on 24 September in London, where it plans to detail progress on its profit improvement plan and its roadmap for improving profitability over the medium term. Until then, Tuesday’s update offers markets a clearer signal that the recovery flagged in the spring is gaining traction, though the scale of the rebound will depend on whether the momentum in aerospace and electronics can be sustained through the final quarter.